⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,834.65
−0.29%
FTSE ADX
9,829.37
+0.47%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,720.68
+0.39%
Nasdaq 100
29,559.79
+0.10%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.58
+0.25%
ADX:IHC
AED 356.60
+1.31%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$217.01
−0.04%
NYSE:TSM
$427.21
+1.66%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,123.91
−0.41%
Brent
$108.77
−0.42%
BTC
$82,455.48
+0.75%
ETH
$2,439.79
+1.44%
DFM General
5,834.65
−0.29%
FTSE ADX
9,829.37
+0.47%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,720.68
+0.39%
Nasdaq 100
29,559.79
+0.10%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.58
+0.25%
ADX:IHC
AED 356.60
+1.31%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$217.01
−0.04%
NYSE:TSM
$427.21
+1.66%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,123.91
−0.41%
Brent
$108.77
−0.42%
BTC
$82,455.48
+0.75%
ETH
$2,439.79
+1.44%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Open
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Summit Therapeutics Inc · News · TradingHolo
Markets
›
United States
› NAS
› SMMT
S
Summit Therapeutics Inc
NAS:SMMT
Healthcare
NASDAQ:NBI
NASDAQ:NQUSMG
$15.78
+1.32%
Live
In session · ≈
AED 57.93
· Market cap
$12.58B
· Next earnings
Wed 11 Nov
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
SMMT news
Headlines tagged to this company
RE
Major drugmakers turn to China for licensing deals
Reuters · 27 h ago
RE
Summit Therapeutics Announces Opening Of Global Phase Ii Study Of Ivonescimab-Based Regimens In Advanced Clear Cell Renal Cell Carcinoma
Reuters · 29 h ago
TR
Summit Therapeutics Inc. (SMMT) Opens Global Phase II Study in Advanced RCC
TradingView · 30 h ago
SE
Catalyst Watch: Meta earnings, Kroger event, and Black Monday turns 39
Seeking Alpha · 4 d ago
SE
AstraZeneca inks AI drug discovery deal worth up to $1.5B with insitro
Seeking Alpha · 5 d ago
LO
REG - AstraZeneca PLC - AstraZeneca completes equity investment in Summit
London Stock Exchange · 15 d ago
BU
AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics
BusinessWire · 15 d ago
TR
Summit Therapeutics Inc. (SMMT) Closes $2B Equity Investment From AstraZeneca
TradingView · 15 d ago
SE
Trending stocks this week as markets weigh jobs data, yields
Seeking Alpha · 16 d ago
GU
AstraZeneca Stocks Moves Lower as Datroway Combination Enters Phase 3
GuruFocus · 18 d ago
RE
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination
Reuters · 18 d ago
RE
Mergers and acquisitions
Reuters · 18 d ago
SH
Weekly review
ShareCast · 18 d ago
ST
Summit Teams Up With Daiichi Sankyo, AstraZeneca For Cancer Therapy Trial – CEO Calls It An ‘Important Expansion’
Stocktwits · 18 d ago
SE
AstraZeneca, Daiichi Sankyo collaborate with Summit Therapeutics to evaluate Datroway-ivonescimab combo
Seeking Alpha · 18 d ago
RE
AstraZeneca & Daiichi Sankyo announce clinical collaboration with Summit Therapeutics
Reuters · 18 d ago
More news →